Carman Man Chung Li, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Haploinsufficiency | 1 | 2024 | 337 | 0.820 |
Why?
|
Mammary Glands, Animal | 2 | 2022 | 271 | 0.690 |
Why?
|
BRCA1 Protein | 2 | 2024 | 1155 | 0.620 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.510 |
Why?
|
Stromal Cells | 1 | 2020 | 1330 | 0.490 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2013 | 306 | 0.380 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3802 | 0.370 |
Why?
|
Epithelial Cells | 2 | 2021 | 3673 | 0.330 |
Why?
|
Neoplasm Metastasis | 3 | 2017 | 4915 | 0.310 |
Why?
|
Adenocarcinoma | 4 | 2017 | 6346 | 0.300 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2024 | 8547 | 0.280 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2416 | 0.260 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18252 | 0.260 |
Why?
|
Phosphoproteins | 1 | 2013 | 2448 | 0.230 |
Why?
|
Lung Neoplasms | 4 | 2017 | 13380 | 0.220 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11903 | 0.210 |
Why?
|
Aging | 1 | 2020 | 8708 | 0.190 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5796 | 0.180 |
Why?
|
Gene Knockdown Techniques | 2 | 2015 | 1612 | 0.170 |
Why?
|
Mammary Glands, Human | 1 | 2020 | 203 | 0.160 |
Why?
|
Mice, Nude | 2 | 2015 | 3615 | 0.150 |
Why?
|
Tenascin | 1 | 2017 | 62 | 0.140 |
Why?
|
Genes, Tumor Suppressor | 1 | 2020 | 1062 | 0.130 |
Why?
|
Germ-Line Mutation | 1 | 2024 | 1858 | 0.130 |
Why?
|
Breast | 2 | 2022 | 1967 | 0.130 |
Why?
|
Transcription Factors | 1 | 2015 | 12128 | 0.130 |
Why?
|
Single-Cell Analysis | 3 | 2020 | 2449 | 0.120 |
Why?
|
Cell Communication | 1 | 2021 | 1657 | 0.120 |
Why?
|
Organoids | 1 | 2020 | 740 | 0.110 |
Why?
|
Microfluidics | 1 | 2019 | 653 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 698 | 0.110 |
Why?
|
Lymphocytes | 1 | 2020 | 2612 | 0.100 |
Why?
|
Chromatin | 1 | 2024 | 2960 | 0.100 |
Why?
|
Phosphate-Binding Proteins | 1 | 2013 | 93 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2020 | 1667 | 0.100 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2019 | 803 | 0.100 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2019 | 946 | 0.100 |
Why?
|
Cell Lineage | 1 | 2020 | 2555 | 0.090 |
Why?
|
Stem Cells | 2 | 2021 | 3522 | 0.090 |
Why?
|
Animals, Genetically Modified | 1 | 2015 | 1561 | 0.090 |
Why?
|
Mice | 6 | 2024 | 81525 | 0.090 |
Why?
|
Animals | 8 | 2024 | 168459 | 0.090 |
Why?
|
Cell Line, Tumor | 3 | 2019 | 16981 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2020 | 2747 | 0.080 |
Why?
|
Gene Silencing | 1 | 2015 | 1509 | 0.080 |
Why?
|
Protein Isoforms | 1 | 2013 | 1699 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1745 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3639 | 0.080 |
Why?
|
Flow Cytometry | 1 | 2019 | 5869 | 0.080 |
Why?
|
Proteomics | 2 | 2022 | 3849 | 0.070 |
Why?
|
Breast Neoplasms | 3 | 2024 | 21012 | 0.070 |
Why?
|
Cell Differentiation | 2 | 2021 | 11528 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2917 | 0.060 |
Why?
|
Macrophages | 1 | 2020 | 5769 | 0.060 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2016 | 1727 | 0.060 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3595 | 0.060 |
Why?
|
Cells, Cultured | 1 | 2020 | 18965 | 0.060 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 22169 | 0.060 |
Why?
|
Extracellular Matrix | 2 | 2021 | 1726 | 0.050 |
Why?
|
Survival Analysis | 1 | 2013 | 10090 | 0.040 |
Why?
|
Biomedical Engineering | 1 | 2021 | 288 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5368 | 0.040 |
Why?
|
Female | 5 | 2024 | 392644 | 0.040 |
Why?
|
Annexin A2 | 1 | 2017 | 44 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2020 | 701 | 0.040 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 687 | 0.030 |
Why?
|
S100 Proteins | 1 | 2017 | 218 | 0.030 |
Why?
|
Humans | 7 | 2024 | 761504 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2021 | 1685 | 0.030 |
Why?
|
Regeneration | 1 | 2021 | 1511 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2020 | 1961 | 0.030 |
Why?
|
Disease Progression | 2 | 2017 | 13506 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 22170 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6132 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15601 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3877 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9539 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12059 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9420 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10445 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29874 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23445 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29625 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59243 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 64680 | 0.010 |
Why?
|
Middle Aged | 1 | 2020 | 220895 | 0.000 |
Why?
|
Adult | 1 | 2020 | 221177 | 0.000 |
Why?
|
Male | 1 | 2017 | 360804 | 0.000 |
Why?
|